Genetic Engineering and Biotechnology News (GEN), the only high-frequency publication dedicated to biotech news, from bench to business, was introduced in 1981 as the first biotechnology trade publication. Now in its 27th year, GEN retains its position as the most widely read biotechnology publication around the globe.
Published 21 times a year, GEN's unique news and technology content focus includes the entire bioproduct life cycle from early-stage R&D to applied research and bioprocess through to commercialization. GEN is the only publication that provides the full range of the biotechnology market coverage in areas such as omics, drug and biomarker discovery, bioprocessing, clinical research, molecular diagnostics, and biobusiness.
Published 21 times a year, GEN's unique news and technology content focus includes the entire bioproduct life cycle from early-stage R&D to applied research and bioprocess through to commercialization. GEN is the only publication that provides the full range of the biotechnology market coverage in areas such as omics, drug and biomarker discovery, bioprocessing, clinical research, molecular diagnostics, and biobusiness.
Request your copy
No hidden or trial offers, and no purchase necessary, publications are absolutely free to professionals who qualify.
No hidden or trial offers, and no purchase necessary, publications are absolutely free to professionals who qualify.
